Bio-Techne Corporation
TECH · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $8,104 | $11,293 | $12,831 | $13,595 |
| - Cash | $162 | $152 | $181 | $173 |
| + Debt | $444 | $420 | $455 | $326 |
| Enterprise Value | $8,386 | $11,561 | $13,105 | $13,748 |
| Revenue | $1,220 | $1,159 | $1,137 | $1,106 |
| % Growth | 5.2% | 2% | 2.8% | – |
| Gross Profit | $790 | $770 | $770 | $756 |
| % Margin | 64.8% | 66.4% | 67.7% | 68.4% |
| EBITDA | $217 | $313 | $457 | $414 |
| % Margin | 17.8% | 27% | 40.2% | 37.4% |
| Net Income | $73 | $168 | $285 | $272 |
| % Margin | 6% | 14.5% | 25.1% | 24.6% |
| EPS Diluted | 0.46 | 1.05 | 1.76 | 1.66 |
| % Growth | -56.2% | -40.3% | 6% | – |
| Operating Cash Flow | $288 | $299 | $254 | $325 |
| Capital Expenditures | -$31 | -$63 | -$38 | -$45 |
| Free Cash Flow | $257 | $236 | $216 | $280 |